{"protocolSection":{"identificationModule":{"nctId":"NCT05671705","orgStudyIdInfo":{"id":"VC22ONDI0185"},"organization":{"fullName":"The Catholic University of Korea","class":"OTHER"},"briefTitle":"Effect of Sarcopenia in Stroke Patients","officialTitle":"Effect of Sarcopenia in Stroke Patients"},"statusModule":{"statusVerifiedDate":"2023-03","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-01-06","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-06","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-06","type":"ESTIMATED"},"studyFirstSubmitDate":"2022-11-24","studyFirstSubmitQcDate":"2023-01-03","studyFirstPostDateStruct":{"date":"2023-01-05","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-03-26","lastUpdatePostDateStruct":{"date":"2023-03-28","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Sun Im","investigatorTitle":"MD., PhD.","investigatorAffiliation":"The Catholic University of Korea"},"leadSponsor":{"name":"The Catholic University of Korea","class":"OTHER"},"collaborators":[{"name":"Saint Vincent's Hospital, Korea","class":"OTHER"}]},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Primary research purpose:\n\n-Prospective study to screen post stroke patients with sarcopenia and evaluate its effect on recovery\n\nSecondary research purpose:\n\n* To determine the degree of sarcopenia and correlation with poor functional prognosis of stroke in the stroke patient group.\n* To determine the degree of sarcopenia and correlation with dixon MRI of thigh muscle\n* To evaluate surface EMG (SEMG)-based signals and correlation with sarcopenia\n* To determine the degree of sarcopenia and correlation with brain morphometric changes","detailedDescription":"Patients with first-ever stroke will be enrolled and assessed for sarcopenia. The evaluation parameters will include standard sarcopenia parameters and also SEMG-based signals and imaging studies."},"conditionsModule":{"conditions":["Stroke","Sarcopenia"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":88,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Stroke patients with sarcopenia","description":"Group will be stratified according to gender","interventionNames":["Diagnostic Test: DEXA Scan"]},{"label":"Stroke patients without sarcopenia","description":"Group will be stratified according to gender","interventionNames":["Diagnostic Test: DEXA Scan"]}],"interventions":[{"type":"DIAGNOSTIC_TEST","name":"DEXA Scan","description":"Fu of diagnostic tests","armGroupLabels":["Stroke patients with sarcopenia","Stroke patients without sarcopenia"],"otherNames":["Serum biomarkers, SEMG signals and MRI changes"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change of Modified Rankin Scale","description":"Functional Disability -\\> The scale runs from 0-6, running from perfect health without symptoms(0) to death(6).","timeFrame":"6 months from the first onset of the stroke"}],"secondaryOutcomes":[{"measure":"Hand grip strength","description":"Grip strength: Grip strength will be measured using a dynamometer","timeFrame":"within 4 weeks, 4 weeks, 8 weeks, 6 months from the first onset of the stroke"},{"measure":"quadriceps muscle strength","description":"Lower extremity strength assessment:change in isometric quadriceps muscle strength (kg) from initial evaluation to the final evaluation","timeFrame":"within 4 weeks, 4 weeks, 8 weeks, 6 months from the first onset of the stroke"},{"measure":"Fugl-Meyer motor scale","description":"Motor function assessment : Fugl-Meyer motor scale from initial evaluation to the final evaluation (Upper Extremity maximum score = 66; Lower Extremity maximum score = 34, Higher score means better outcome)","timeFrame":"within 4 weeks, 4 weeks, 8 weeks, 6 months from the first onset of the stroke"},{"measure":"Functional Ambulation Category","description":"Gait function assessment : Functional Ambulation Category from initial evaluation to the final evaluation (Minimum 0, Maximum 5; Higher score means better outcome)","timeFrame":"within 4 weeks, 4 weeks, 8 weeks, 6 months from the first onset of the stroke"},{"measure":"Berg balance scale","description":"Balance function: change in Berg balance scale from initial evaluation to the final evaluation (Minimum score 0, Maximum score 56, Higher score means better outcome)","timeFrame":"within 4 weeks, 4 weeks, 8 weeks, 6 months from the first onset of the stroke"},{"measure":"Brain MRI","description":"Brain atrophy : change in the Global cortical atrophy scale(0-3) of the cerebral cortex from initial evaluation to the final evaluation","timeFrame":"within 4 weeks and 6 months from the first onset of the stroke"},{"measure":"Thigh Dixon MRI","description":"Muscle quality : muscle circumference measured by the thigh MRI from initial evaluation to the final evaluation","timeFrame":"within 4 weeks and 6 months from the first onset of the stroke"},{"measure":"Muscle ultrasonography","description":"muscle thickness(cm) measured by the ultrasound of the quadriceps muscle from initial evaluation to the final evaluation","timeFrame":"within 4 weeks and 6 months from the first onset of the stroke"},{"measure":"serum biomarkers for sarcopenia","description":"BNDF, IL-6","timeFrame":"within 4 weeks from the first onset of the stroke"},{"measure":"Digitalized SEMG signals","description":"state of the art EMG signals will be collected to assess muscle quality changes after stroke","timeFrame":"within 4 weeks, 4 weeks, 8 weeks, 6 months from the first onset of the stroke"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients 65 years of age or older, stroke patients with first onset within 4 weeks\n\nExclusion Criteria:\n\n* Patients who have not been evaluated for sarcopenia\n* Patients with neuromuscular diseases other than stroke that may affect gait function\n* Patients unable to conduct clinical trials according to instructions\n* Patients with uncontrolled medical/surgical disease\n* Patients with metal substances in the body such as cardiac pacemakers, cochlear implants, etc.\n* Patients who have difficulty collecting blood\n* Patients who are difficult to follow up after 6 months of onset due to moving to another area\n* Patients who have Parkinson's disease, dementia, or have a history of neuromuscular diseases such as Guillain-Barr√© syndrome or myasthenia gravis","healthyVolunteers":false,"sex":"ALL","minimumAge":"65 Years","stdAges":["OLDER_ADULT"],"studyPopulation":"Recruited subjects will be allocated into 4 different groups according to presence of sarcopenia according to the Asian Working Group for Sarcopenia (2019) criteria.\n\n* Post stroke male patients with sarcopenia\n* Post stroke female patients with sarcopenia\n* Post stroke male patients without sarcopenia\n* Post stroke female patients without sarcopenia","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Sun Im, MD PhD","role":"CONTACT","phone":"+*-032-340-2170","email":"lafolia@catholic.ac.kr"}],"locations":[{"facility":"The Catholic University of Korea","status":"RECRUITING","city":"Bucheon-si, Gyeonggi-do","zip":"14647","country":"Korea, Republic of","contacts":[{"name":"Sun Im, Dr.","role":"CONTACT"}],"geoPoint":{"lat":37.49889,"lon":126.78306}},{"facility":"St. Vincent's Hospital","status":"NOT_YET_RECRUITING","city":"Suwon-si","zip":"16247","country":"Korea, Republic of","contacts":[{"name":"Yeun Jie Yoo, Dr.","role":"CONTACT"}],"geoPoint":{"lat":37.29111,"lon":127.00889}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000055948","term":"Sarcopenia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000009133","term":"Muscular Atrophy"},{"id":"D000020879","term":"Neuromuscular Manifestations"},{"id":"D000009461","term":"Neurologic Manifestations"},{"id":"D000001284","term":"Atrophy"},{"id":"D000020763","term":"Pathological Conditions, Anatomical"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M28086","name":"Sarcopenia","asFound":"Sarcopenia","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M11780","name":"Muscular Atrophy","relevance":"LOW"},{"id":"M4279","name":"Atrophy","relevance":"LOW"},{"id":"M22309","name":"Neuromuscular Manifestations","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"},{"id":"M22209","name":"Pathological Conditions, Anatomical","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}